首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >The ferritin Fe2 site at the diiron catalytic center controls the reaction with O2 in the rapid mineralization pathway
【2h】

The ferritin Fe2 site at the diiron catalytic center controls the reaction with O2 in the rapid mineralization pathway

机译:二铁催化中心的铁蛋白Fe2位点控制着快速矿化路径中与O2的反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Oxidoreduction in ferritin protein nanocages occurs at sites that bind two Fe(II) substrate ions and O2, releasing Fe(III)2–O products, the biomineral precursors. Diferric peroxo intermediates form in ferritins and in the related diiron cofactor oxygenases. Cofactor iron is retained at diiron sites throughout catalysis, contrasting with ferritin. Four of the 6 active site residues are the same in ferritins and diiron oxygenases; ferritin-specific Gln137 and variable Asp/Ser/Ala140 substitute for Glu and His, respectively, in diiron cofactor active sites. To understand the selective functions of diiron substrate and diiron cofactor active site residues, we compared oxidoreductase activity in ferritin with diiron cofactor residues, Gln137 → Glu and Asp140 → His, to ferritin with natural diiron substrate site variations, Asp140, Ser140, or Ala140. In Gln137 → Glu ferritin, diferric peroxo intermediates were undetectable; an altered Fe(III)–O product formed, ΔA350 = 50% of wild type. In Asp140 → His ferritin, diferric peroxo intermediates were also undetectable, and Fe(II) oxidation rates decreased 40-fold. Ferritin with Asp140, Ser140, or Ala140 formed diferric peroxo intermediates with variable kinetic stabilities and rates: t1/2 varied 1- to 10-fold; kcat varied approximately 2- to 3-fold. Thus, relatively small differences in diiron protein catalytic sites determine whether, and for how long, diferric peroxo intermediates form, and whether the Fe–active site bonds persist throughout the reaction cycle (diiron cofactors) or break to release Fe(III)2–O products (diiron substrates). The results and the coding similarities for cofactor and substrate site residues—e.g., Glu/Gln and His/Asp pairs share 2 of 3 nucleotides—illustrate the potential simplicity of evolving active sites for diiron cofactors or diiron substrates.
机译:铁蛋白蛋白质纳米笼中的氧化还原发生在结合两个Fe(II)底物离子和O2的位点,释放出Fe(III)2-O产物,即生物矿物的前体。二价过氧中间体在铁蛋白和相关的二铁辅因子加氧酶中形成。与铁蛋白相反,辅酶在整个催化过程中保留在二铁部位。铁蛋白和二铁氧化酶中6个活性位点残基中的4个相同;铁蛋白特异的Gln 137 和可变的Asp / Ser / Ala 140 在二铁辅因子活性位点分别替代Glu和His。为了了解二铁底物和二铁辅因子活性位点残基的选择性功能,我们将铁蛋白中的氧化还原酶活性与二铁辅因子残基Gln 137 →Glu和Asp 140 →His,天然铁蛋白底物位点变化的铁蛋白,Asp 140 ,Ser 140 或Ala 140 。在Gln 137 →Glu铁蛋白中,未检测到二铁过氧中间体。 Fe(III)–O生成的改变产物,ΔA350=野生型的50%。在Asp 140 →他的铁蛋白中,也检测不到二铁过氧中间体,Fe(II)的氧化速率降低了40倍。铁蛋白与Asp 140 ,Ser 140 或Ala 140 形成的二铁过氧中间体具有可变的动力学稳定性和速率:t1 / 2在1- 10倍; kcat变化约2至3倍。因此,二铁蛋白催化位点的相对较小差异决定了二铁过氧中间体是否形成以及持续多长时间,以及铁活性位键在整个反应周期中是否持续存在(二铁辅因子)或断裂以释放Fe(III)2- O产品(二铁基质)。辅因子和底物位点残基的结果以及编码相似性(例如,Glu / Gln和His / Asp对共享3个核苷酸中的2个),说明了改变二铁辅因子或二铁底物活性位点的潜在简便性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号